Concerned about the rising levels of drug resistance whereby microbes evolve to become immune to a known drugs, the UK Prime Minister asked economist Jim O’Neill to analyse this global problem of antimicrobial resistance (AMR) and propose concrete actions to tackle it internationally. In July 2014, the UK Government commissioned the Review on Antimicrobial Resistance...

Analyses the impact of nearly 200 diseases and injuries in terms of living with illness (non-fatal burden) and premature death (fatal burden). Summary Burden of disease analysis is a way to compare the impact of different diseases, conditions or injuries on a population. This impact can be broadly divided into non-fatal (living with a disease)...

The term chronic disease applies to a group of diseases that tend to be long lasting and have persistent effects. This is opposed to acute diseases, which have a quick onset and are often brief, intense and/or severe.

The global action plan of the World Health Organization (WHO) for preventing and controlling non-communicable diseases aims to substantially reduce the burden of premature mortality caused by cancer, diabetes, cardiovascular disease and chronic lung disease by 2025, through action on nine targets measured by 25 indicators of performance. As a member state of the WHO...

Ineffective management of heart disease, asthma, diabetes and other chronic diseases costs the Australian health system more than $320 million each year in avoidable hospital admissions. At best, the Australian primary care system provides only half the recommended care for many chronic conditions. Only a quarter of the nearly one million Australians diagnosed with type...